{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/SSME/SE0008216329",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Enorama Pharma AB (First North Sweden: SE0008216329) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Enorama Pharma AB, listed on First North Sweden under the ticker SE0008216329, with ISIN SE0008216329 and LEI 5493008ICNN7HHKZWL40. Security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 44 filings in the twelve months to 2026-11-06, across 27 filing days. Of these, 35 are Company Announcements, 4 are Interim reports (Q1 and Q3), 2 are Decisions of general meeting, 2 are Notices to general meeting, and 1 is a Changes in board/management/certified adviser/auditor/liquidity provider filing. The median gap between filing days is 8.0 days, and the latest filing is 7 days before the record date. The exchange median is 11.0 days of cadence gap, 21 filings and 7 days of latency across 325 issuers. The sector median is not on the record. The latest filing is a Company Announcement dated 2026-10-30.\n\n## Auditor\n\nThe auditor of record and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The issuer is listed and not halted.\n\n## Orderability\n\nThe outcome cannot be determined under rule version acm-68000/se/mifid-ii-product-governance/r1, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page.\n\n## Open research\n\nNo openly published research notes were found.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No sealed years hold the issuer, and the market's earliest sealed date and the start of the live record are not on the record.\n\n## Sources\n\n6 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/SSME/SE0008216329 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.se-cm-kg.ai/record/SSME/SE0008216329 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/SSME/SE0008216329",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 325,
     "median_cadence_gap_days": 11,
     "median_filings": 21,
     "median_latency_days": 7,
     "name": "First North Sweden"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Changes in board/management/certified adviser/auditor/liquidity provider": 1,
    "Company Announcement": 35,
    "Decisions of general meeting": 2,
    "Interim report (Q1 and Q3)": 4,
    "Notice to general meeting": 2
   },
   "cadence_median_gap_days": 8,
   "filing_days": 27,
   "filings": 44,
   "latency_days": 7,
   "latest": [
    {
     "category": "Company Announcement",
     "date": "2026-10-30",
     "source": "https://view.news.eu.nasdaq.com/view?id=b9762227e4d0267a4e9f130f203bf4ee8&lang=sv&src=listed",
     "title": "Enorama Pharma AB (publ) häver avtalet om överlåtelse av nikotintuggummiverksamheten med Aflofarm",
     "type": "Company Announcement"
    },
    {
     "category": "Company Announcement",
     "date": "2026-10-28",
     "source": "https://view.news.eu.nasdaq.com/view?id=b1995578281838768c7a4c77d19cfe1db&lang=sv&src=listed",
     "title": "Jonas Brisland avgår som CFO för Enorama Pharma AB (publ)",
     "type": "Company Announcement"
    },
    {
     "category": "Company Announcement",
     "date": "2026-10-21",
     "source": "https://view.news.eu.nasdaq.com/view?id=b02d3c478812d3269b8398047d588bc91&lang=sv&src=listed",
     "title": "Enorama Pharma ingår dels avtal för tillverkning, dels avtal för distribution av NIC-S inom EU och Storbritannien",
     "type": "Company Announcement"
    },
    {
     "category": "Interim report (Q1 and Q3)",
     "date": "2026-08-19",
     "source": "https://view.news.eu.nasdaq.com/view?id=b565e611cccf89cd32534e03b31756b0c&lang=sv&src=listed",
     "title": "Kvartalsrapport - Enorama Pharma AB (publ)",
     "type": "Interim report (Q1 and Q3)"
    },
    {
     "category": "Changes in board/management/certified adviser/auditor/liquidity provider",
     "date": "2026-07-15",
     "source": "https://view.news.eu.nasdaq.com/view?id=bdcec63b51e7905b0c06e48750df7f75b&lang=sv&src=listed",
     "title": "Enorama Pharma AB (publ) meddelar Bengt Jönssons avgång och utnämningen av Amy Walker som tillförordnad verkställande direktör",
     "type": "Changes in board/management/certified adviser/auditor/liquidity provider"
    }
   ],
   "latest_filing_date": "2026-10-30",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0008216329",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "First North Sweden"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0008216329"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0008216329)",
    "state": "sourced",
    "value": "5493008ICNN7HHKZWL40"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Enorama Pharma AB"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0008216329"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:ffd4dd774e808d57a7a4b4765ff975818f3957108df8dc51f9a5ceaabba88dc4",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/SSME/SE0008216329",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:ffd4dd774e808d57a7a4b4765ff975818f3957108df8dc51f9a5ceaabba88dc4",
 "path": "/se/SSME/SE0008216329",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Enorama Pharma AB, listed on First North Sweden under the ticker SE0008216329, with ISIN SE0008216329 and LEI 5493008ICNN7HHKZWL40. Security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 44 filings in the twelve months to 2026-11-06, across 27 filing days. Of these, 35 are Company Announcements, 4 are Interim reports (Q1 and Q3), 2 are Decisions of general meeting, 2 are Notices to general meeting, and 1 is a Changes in board/management/certified adviser/auditor/liquidity provider filing. The median gap between filing days is 8.0 days, and the latest filing is 7 days before the record date. The exchange median is 11.0 days of cadence gap, 21 filings and 7 days of latency across 325 issuers. The sector median is not on the record. The latest filing is a Company Announcement dated 2026-10-30.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome cannot be determined under rule version acm-68000/se/mifid-ii-product-governance/r1, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations page.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No sealed years hold the issuer, and the market's earliest sealed date and the start of the live record are not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "6 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0008216329"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/SSME/SE0008216329"
  }
 ],
 "title": "Enorama Pharma AB (SE0008216329) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}